Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lupin
Pharma
BMS-BeiGene, Sumitomo-Otsuka, AstraZeneca—Fierce Pharma Asia
BMS and BeiGene scrapped their legacy Celgene deal. Sumitomo and Otsuka's schizophrenia drug failed in two phase 3 tests. AZ's CEO talked about China.
Angus Liu
Aug 4, 2023 8:50am
Lupin recalls birth control pills deemed possibly ineffective
Aug 1, 2023 8:21am
BeiGene-Novartis, Takeda, Eisai and more—Fierce Pharma Asia
Jul 14, 2023 9:20am
Lupin gets off light after FDA manufacturing plant inspection
Jul 12, 2023 2:19pm
Lupin scores FDA nod for first generic version of BI's Spiriva
Jun 22, 2023 8:00am
Intas' Gujarat, India facility is in the FDA's crosshairs
Jan 20, 2023 10:17am